医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

KCAS Bio and Crux Biolabs Announce Global Spectral Flow Cytometry Alliance
CAS Bio continues to deliver against both growth objectives and more integrated customer service offerings. KCAS Bio has partnered with Crux Biolabs, a leading provider of flow cytometry and bioanalytical services located in Melbourne, Australia. KCAS Bio is a leading international Contract Research Organization (CRO) providing comprehensive GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and cell/gene therapy industries. KCAS Bio offers a complete range of bioanalytical services from early discovery support through registration, providing expertise in biological (large molecule), synthetic (small molecule), and cell/gene therapy drug candidates. KCAS Bio provides services from its three locations in Kansas City, KS; the greater Philadelphia, PA, region; and Lyon, France.… 続きを読む
2024年05月04日 AM12:20
2024年05月03日
Firstsource Acquires Quintessence
irstsource Solutions Limited (NSE: FSL, BSE:532809), a global provider of Business Process Management (BPM) services and an RP-Sanjiv Goenka Group company, has acquired Quintessence Business Solutions & Services Private Limited, an India-based leader in outsourced revenue cycle management (RCM) services and technology. This strategic acquisition further strengthens Firstsource’s RCM solutions offerings, providing more comprehensive and AI-enabled RCM solutions for health systems, and growing its offshore capabilities.… 続きを読む
2024年05月03日
Dr. Reddy’s Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
r. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA® (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).… 続きを読む
2024年05月03日
パース・バイオサイエンシズ、シングル・セル免疫プロファイリング製品を発表
アクセス性と拡張性に優れたシングル・セル・シーケンス・ソリューションを提供する大手企業のパース・バイオサイエンシズは、「Evercode™BCR」の提供開始および既存の「Evercode™TCR」製品ラインの拡充を発表しました。新たなBCRソリューションと既存のTCR製品ラインへのアップデートは、パースのシングル・セル・ポートフォリオを拡充し、またこれにより、研究者はかつてないほどの解像度と規模で免疫レパートリーを研究することができるようになります。… 続きを読む
2024年05月03日
Parse Biosciences推出单细胞免疫分析产品
Parse Biosciences是一家领先的提供易于获取和可扩展的单细胞测序解决方案的供应商。该公司今天宣布推出Evercode™ BCR,并扩展了其现有的Evercode™ TCR产品线。新的BCR解决方案和现有TCR产品线的更新扩展了Parse的单细胞产品组合,将使研究人员能够以前所未有的分辨率和规模研究免疫复合物。… 続きを読む